About this trial
This is a randomized pilot interventional study aimed at evaluating the effect of a dietary supplement containing EGCG, vitamin B12, hyaluronic acid, and folic acid on the maintenance of physiological balance and natural defenses of the male genital tract in subjects exposed to HPV infection and seeking care for infertility at natural procreation centers. The study includes 48 couples (96 participants) recruited at the International Scientific Institute "Paolo VI" of the A. Gemelli Policlinico, randomly assigned to two groups: 24 couples in which both partners receive one oral tablet per day of the supplement for 6 months, and 24 control couples receiving no supplementation. In addition to the primary objective, secondary outcomes assess potential support of sperm parameters, reproductive well-being of the couples, maintenance of genital mucosal physiological balance with possible reduction of HPV transmission risk to female partners, and support of physiological balance in the presence of co-infections or alterations of the genital microbiota.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Signed informed consent
Couple seeking pregnancy
Male partner aged 25-65 years
HPV DNA test indicating active HPV infection in the male partner
Disqualifiers
Concomitant diseases causing immunosuppression
Treatment with immunomodulatory therapies
Use of EGCG or other green tea extracts
Trial design
Parallel
Treatments tested in this trial
Pervistop
Dietary supplementcombination of EGCG, vitamin B12, hyaluronic acid, and folic acid.
Treatment groups
Trial outcomes
Primary outcomes
The aim of the study is to evaluate the effect of a combination of EGCG, vitamin B12, hyaluronic acid, and folic acid on the maintenance of physiological balance and natural defense mechanisms of the male genital tract in subjects who, due to infertility
The aim is to ensure continued HPV test negativity in the male partner throughout the six-month course of Pervistop therapy. The presence of the viral genotype will be determined by urethral swab sampling, followed by gene amplification using polymerase chain reaction (PCR) methodology.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead sponsor
Lo.Li.Pharma s.r.l
Collaborator
This trial is not recruiting at the moment. You can still explore other options: